https://www.sciencedaily.com/news/health_medicine/infectious_diseases/ Read the latest medical research on the prevention, management, and treatment of infectious diseases. Read articles on HINI, influenza, C. difficile, HIV and AIDS, hepatitis, herpes, STDs and more. en-us Mon, 20 Apr 2026 02:42:35 EDT Mon, 20 Apr 2026 02:42:35 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/infectious_diseases/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260416071953.htm Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers. Fri, 17 Apr 2026 07:44:05 EDT https://www.sciencedaily.com/releases/2026/04/260416071953.htm https://www.sciencedaily.com/releases/2026/04/260413043138.htm Public restrooms might seem like a germ nightmare, but the real risks aren’t always where you think. While toilet seats can carry bacteria, viruses, and even parasite traces, studies show they’re often cleaner than high-touch surfaces like door handles and flush levers. The biggest hidden threat comes from “toilet plumes”—tiny germ-filled droplets launched into the air when flushing without a lid—and from poor hand hygiene. Mon, 13 Apr 2026 22:49:20 EDT https://www.sciencedaily.com/releases/2026/04/260413043138.htm https://www.sciencedaily.com/releases/2026/04/260411022027.htm A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines. Sun, 12 Apr 2026 06:42:12 EDT https://www.sciencedaily.com/releases/2026/04/260411022027.htm https://www.sciencedaily.com/releases/2026/04/260409101106.htm Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective. Fri, 10 Apr 2026 22:31:35 EDT https://www.sciencedaily.com/releases/2026/04/260409101106.htm https://www.sciencedaily.com/releases/2026/04/260406192907.htm A surprising new study reveals that what you eat could play a powerful role in fighting cholera, a deadly diarrheal disease. Researchers found that diets rich in certain proteins—especially casein from dairy and wheat gluten—can dramatically reduce the ability of cholera bacteria to take hold in the gut, in some cases cutting infection levels by up to 100 times. These proteins appear to disable a key “weapon” the bacteria use to attack other microbes and dominate the gut environment. Tue, 07 Apr 2026 03:22:01 EDT https://www.sciencedaily.com/releases/2026/04/260406192907.htm https://www.sciencedaily.com/releases/2026/04/260405003949.htm Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for hepatitis C, was found to block the virus from replicating by disrupting its genetic machinery. Tests in cells and animals showed strong effectiveness without harming healthy tissue. If ongoing trials succeed, the drug could soon be repurposed for hepatitis E. Mon, 06 Apr 2026 05:00:20 EDT https://www.sciencedaily.com/releases/2026/04/260405003949.htm https://www.sciencedaily.com/releases/2026/03/260331001054.htm A breakthrough urine test could dramatically speed up how doctors treat urinary tract infections, identifying the right antibiotic in under six hours instead of waiting days. By testing directly from urine—skipping the usual lab culturing step—the method quickly shows which drugs stop bacterial growth and which don’t. In trials involving hundreds of patient samples, the test proved highly accurate, matching standard methods in over 96% of cases. Tue, 31 Mar 2026 01:45:05 EDT https://www.sciencedaily.com/releases/2026/03/260331001054.htm https://www.sciencedaily.com/releases/2026/03/260325005922.htm Long COVID remains a frustrating medical mystery, affecting up to 1 in 10 people long after the initial infection fades. Now, scientists have uncovered a crucial clue hidden deep within the immune system. By analyzing individual immune cells, they identified a distinct molecular state in key white blood cells—especially common in patients who initially had mild or moderate COVID. Thu, 26 Mar 2026 07:06:00 EDT https://www.sciencedaily.com/releases/2026/03/260325005922.htm https://www.sciencedaily.com/releases/2026/03/260321012638.htm Antibiotics are accumulating in a major Brazilian river, especially during the dry season when pollution becomes more concentrated. Scientists even detected a banned drug inside fish sold for food, raising concerns about human exposure. A common aquatic plant showed promise in removing these chemicals from water—but it also altered how fish absorb them, creating unexpected risks. Sat, 21 Mar 2026 20:48:07 EDT https://www.sciencedaily.com/releases/2026/03/260321012638.htm https://www.sciencedaily.com/releases/2026/03/260319044659.htm A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications that can lead to heart attacks and strokes. The effect is so strong, it rivals the benefits of quitting smoking. Fri, 20 Mar 2026 08:10:25 EDT https://www.sciencedaily.com/releases/2026/03/260319044659.htm https://www.sciencedaily.com/releases/2026/03/260318033111.htm Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by a rocket-like reaction that breaks down hydrogen peroxide, releasing energy. This motion may help the parasite detoxify harmful chemicals and manage iron more efficiently. The discovery could lead to new drugs and spark innovations in microscopic robotics. Thu, 19 Mar 2026 07:19:27 EDT https://www.sciencedaily.com/releases/2026/03/260318033111.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260315004403.htm Scientists at MIT have discovered that a little-known protein called intelectin-2 plays a powerful double role in defending the gut. The protein strengthens the mucus layer that lines the gastrointestinal tract while also trapping and disabling harmful bacteria that try to break through. By binding to sugars on both mucus molecules and bacterial surfaces, intelectin-2 forms a protective barrier and can even destroy microbes, including some that resist antibiotics. Mon, 16 Mar 2026 00:05:04 EDT https://www.sciencedaily.com/releases/2026/03/260315004403.htm https://www.sciencedaily.com/releases/2026/03/260315001845.htm A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin D3 did not make COVID-19 infections less severe or reduce hospital visits. However, the study uncovered a subtle but intriguing signal suggesting that people who consistently took vitamin D supplements might be slightly less likely to develop long COVID symptoms weeks after infection. Sun, 15 Mar 2026 05:54:54 EDT https://www.sciencedaily.com/releases/2026/03/260315001845.htm https://www.sciencedaily.com/releases/2026/03/260313055130.htm A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later. The increased risk was seen mainly after severe infections that required hospitalization. Vaccination, however, appears to prevent the dangerous lung changes. Fri, 13 Mar 2026 05:56:17 EDT https://www.sciencedaily.com/releases/2026/03/260313055130.htm https://www.sciencedaily.com/releases/2026/03/260313002645.htm In medieval Denmark, people could pay for more prestigious graves closer to the church — a sign of wealth and status. But when researchers examined hundreds of skeletons, they discovered something unexpected: even people with stigmatized diseases like leprosy were buried in these high-status spots. Instead of excluding the sick, many communities appear to have treated them much like everyone else. Fri, 13 Mar 2026 05:38:00 EDT https://www.sciencedaily.com/releases/2026/03/260313002645.htm https://www.sciencedaily.com/releases/2026/03/260311004824.htm A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers found that even a very small dose of EVG7 was highly effective at clearing the infection and preventing it from coming back. Unlike many current antibiotics, which wipe out large portions of the gut microbiome, EVG7 appears to spare beneficial bacteria that naturally help keep C. difficile in check. Wed, 11 Mar 2026 20:19:45 EDT https://www.sciencedaily.com/releases/2026/03/260311004824.htm https://www.sciencedaily.com/releases/2026/03/260306224232.htm A mysterious form of plague that spread across Eurasia thousands of years before the Black Death has finally revealed a crucial clue. Scientists analyzing ancient DNA discovered the bacterium Yersinia pestis in a 4,000-year-old domesticated sheep from a Bronze Age settlement in the Ural Mountains—the first time the pathogen has ever been found in a non-human host from that era. Because this early strain couldn’t spread through fleas like the medieval plague, researchers have long puzzled over how it traveled so widely. Sat, 07 Mar 2026 03:41:28 EST https://www.sciencedaily.com/releases/2026/03/260306224232.htm https://www.sciencedaily.com/releases/2026/03/260306224220.htm Scientists have revealed how the body’s microscopic cold sensor, TRPM8, detects both chilly temperatures and the cooling effect of menthol. The discovery finally shows how the sensation of “cool” works at the molecular level—and could inspire new treatments for pain and eye disorders. Sun, 08 Mar 2026 01:31:56 EST https://www.sciencedaily.com/releases/2026/03/260306224220.htm https://www.sciencedaily.com/releases/2026/03/260304184221.htm Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a traffic controller during the parasite’s unusual cell division process, ensuring its genetic material is properly separated as it multiplies. When scientists switched off ARK1 in laboratory experiments, the parasite could no longer replicate correctly and failed to complete its life cycle in both humans and mosquitoes—effectively halting its ability to spread. Thu, 05 Mar 2026 00:03:04 EST https://www.sciencedaily.com/releases/2026/03/260304184221.htm https://www.sciencedaily.com/releases/2026/02/260228082723.htm Drug-resistant bacteria are becoming harder to treat, pushing scientists to look for new antibiotic targets. Researchers have now discovered that several unrelated viruses disable a key bacterial protein called MurJ, which is essential for building the bacterial cell wall. High-resolution imaging shows these viral proteins lock MurJ into a single position, stopping cell wall construction and leading to bacterial death. Sat, 28 Feb 2026 09:20:04 EST https://www.sciencedaily.com/releases/2026/02/260228082723.htm https://www.sciencedaily.com/releases/2026/02/260225081153.htm A shingles shot might do more than prevent a painful rash — it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who received the shingles vaccine showed slower biological aging compared to those who didn’t. Researchers found lower levels of chronic inflammation and slower changes in gene activity linked to aging, suggesting the vaccine may calm the body’s “inflammaging” — the low-grade inflammation tied to heart disease, frailty, and cognitive decline. Thu, 26 Feb 2026 02:47:45 EST https://www.sciencedaily.com/releases/2026/02/260225081153.htm https://www.sciencedaily.com/releases/2026/02/260224023101.htm Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they’re the perfect breeding ground for these microbes. The team added a genetic tweak that helps the bacteria survive longer near oxygen-exposed edges — but only once enough of them are present to trigger the change. It’s a carefully programmed biological attack that could one day offer a new way to destroy cancer. Tue, 24 Feb 2026 03:41:46 EST https://www.sciencedaily.com/releases/2026/02/260224023101.htm https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260221000321.htm A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline. Sat, 21 Feb 2026 00:43:23 EST https://www.sciencedaily.com/releases/2026/02/260221000321.htm https://www.sciencedaily.com/releases/2026/02/260218031502.htm Deep inside a Romanian ice cave, locked away in a 5,000-year-old layer of ice, scientists have uncovered a bacterium with a startling secret: it’s resistant to many modern antibiotics. Despite predating the antibiotic era, this cold-loving microbe carries more than 100 resistance-related genes and can survive drugs used today to treat serious infections like tuberculosis and UTIs. Sat, 21 Feb 2026 22:38:58 EST https://www.sciencedaily.com/releases/2026/02/260218031502.htm https://www.sciencedaily.com/releases/2026/02/260217005717.htm Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR-based tool that doesn’t just fight resistant bacteria—it can actively strip away their drug resistance. Inspired by gene drives used in insects, the technology spreads a genetic “fix” through bacterial populations, even inside stubborn biofilms that shield microbes from antibiotics. Wed, 18 Feb 2026 03:08:21 EST https://www.sciencedaily.com/releases/2026/02/260217005717.htm https://www.sciencedaily.com/releases/2026/02/260216044006.htm Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components. Wed, 18 Feb 2026 10:00:32 EST https://www.sciencedaily.com/releases/2026/02/260216044006.htm https://www.sciencedaily.com/releases/2026/02/260215085001.htm Researchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, motor skills, behavior, and social development, they found no meaningful differences between vaccinated and unvaccinated groups. Experts say the results provide strong reassurance about vaccine safety in pregnancy. Sun, 15 Feb 2026 09:51:05 EST https://www.sciencedaily.com/releases/2026/02/260215085001.htm https://www.sciencedaily.com/releases/2026/02/260210040608.htm Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our life experiences. Scientists at the Salk Institute have created a detailed epigenetic map of human immune cells, revealing how inherited traits and past exposures—like infections, vaccines, or even environmental chemicals—shape immune responses in different ways. Wed, 11 Feb 2026 00:02:01 EST https://www.sciencedaily.com/releases/2026/02/260210040608.htm https://www.sciencedaily.com/releases/2026/02/260207092906.htm New simulations reveal that both H1N1 and COVID-19 spread across U.S. cities in a matter of weeks, often before officials realized what was happening. Major travel hubs helped drive rapid nationwide transmission, with air travel playing a bigger role than daily commuting. Unpredictable transmission patterns made real-time forecasting especially difficult. The study highlights why early detection systems are critical for slowing future pandemics. Sat, 07 Feb 2026 10:02:31 EST https://www.sciencedaily.com/releases/2026/02/260207092906.htm https://www.sciencedaily.com/releases/2026/02/260206020850.htm Scientists in Australia have uncovered a clever new way to fight some of the most dangerous drug-resistant bacteria by targeting a sugar that exists only on bacterial cells. By designing antibodies that recognize this unique sugar, researchers were able to guide the immune system to attack and eliminate deadly infections that normally shrug off antibiotics. Fri, 06 Feb 2026 04:09:04 EST https://www.sciencedaily.com/releases/2026/02/260206020850.htm https://www.sciencedaily.com/releases/2026/02/260204114343.htm As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage. Wed, 04 Feb 2026 11:43:43 EST https://www.sciencedaily.com/releases/2026/02/260204114343.htm https://www.sciencedaily.com/releases/2026/01/260131084131.htm Researchers in Bangladesh have identified a bat-borne virus, Pteropine orthoreovirus, in patients who were initially suspected of having Nipah virus but tested negative. All had recently consumed raw date-palm sap, a known pathway for bat-related infections. Genetic analysis confirmed live virus in several samples, pointing to active human infection. The finding raises concerns that dangerous bat viruses may be circulating undetected alongside Nipah. Sun, 01 Feb 2026 01:46:23 EST https://www.sciencedaily.com/releases/2026/01/260131084131.htm https://www.sciencedaily.com/releases/2026/01/260128075319.htm A massive international study of more than 3,100 long COVID patients uncovered a striking divide in how brain-related symptoms are reported around the world. In the U.S., the vast majority of non-hospitalized patients described brain fog, depression, and anxiety, while far fewer patients in countries like India and Nigeria reported the same issues. The difference doesn’t appear to be about the virus itself, but about culture, stigma, and access to mental health care. Wed, 28 Jan 2026 08:59:08 EST https://www.sciencedaily.com/releases/2026/01/260128075319.htm https://www.sciencedaily.com/releases/2026/01/260122074702.htm Scientists found that nasal cells act as a first line of defense against the common cold, working together to block rhinovirus soon after infection. A fast antiviral response can stop the virus before symptoms appear. If that response is weakened or delayed, the virus spreads and causes inflammation and breathing problems. The study highlights why the body’s reaction matters more than the virus alone. Thu, 22 Jan 2026 08:15:47 EST https://www.sciencedaily.com/releases/2026/01/260122074702.htm https://www.sciencedaily.com/releases/2026/01/260122074031.htm In Guatemala’s Western Highlands, researchers found that the drinking water people trust most may actually be the riskiest. Bottled water from refillable jugs—seen as the safest choice—was frequently contaminated with harmful bacteria, while protected municipal wells were the cleanest. Fri, 23 Jan 2026 09:53:04 EST https://www.sciencedaily.com/releases/2026/01/260122074031.htm https://www.sciencedaily.com/releases/2026/01/260121034128.htm Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering system for Pseudomonas aeruginosa, an antibiotic-resistant bacterium of global concern, in a new PNAS study. The system is enabled by NEB’s High-Complexity Golden Gate Assembly (HC-GGA) platform. In this method, researchers engineer bacteriophages synthetically using sequence data rather than bacteriophage isolates. Wed, 21 Jan 2026 03:41:28 EST https://www.sciencedaily.com/releases/2026/01/260121034128.htm https://www.sciencedaily.com/releases/2026/01/260120015650.htm Scientists have uncovered a surprising reason why some chronic wounds refuse to heal, even when treated with antibiotics. A common bacterium found in long-lasting wounds does not just resist drugs. It actively releases damaging molecules that overwhelm skin cells and stop them from repairing tissue. Researchers discovered that neutralizing these harmful molecules with antioxidants allows skin cells to recover and restart healing. Tue, 20 Jan 2026 02:35:17 EST https://www.sciencedaily.com/releases/2026/01/260120015650.htm https://www.sciencedaily.com/releases/2026/01/260120015646.htm Scientists have uncovered new clues about why diabetic foot infections can become so severe and difficult to treat. By analyzing the DNA of E. coli bacteria taken from infected wounds around the world, researchers found an unexpected level of diversity, with many strains carrying genes linked to antibiotic resistance and aggressive disease. Rather than a single dangerous strain, multiple types of E. coli appear able to thrive in diabetic foot ulcers, helping explain why infections can worsen quickly and sometimes lead to amputation. Tue, 20 Jan 2026 02:02:20 EST https://www.sciencedaily.com/releases/2026/01/260120015646.htm https://www.sciencedaily.com/releases/2026/01/260120000305.htm A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved gut bacteria, boosted serotonin, and lowered harmful cholesterol and bile acids. Surprisingly, it also reduced circulating levels of antiretroviral drugs while maintaining viral suppression, potentially protecting the liver. Scientists say the results point to a promising new approach for managing chronic complications of HIV. Wed, 21 Jan 2026 01:36:19 EST https://www.sciencedaily.com/releases/2026/01/260120000305.htm https://www.sciencedaily.com/releases/2026/01/260115022808.htm A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies. Fri, 16 Jan 2026 06:06:55 EST https://www.sciencedaily.com/releases/2026/01/260115022808.htm https://www.sciencedaily.com/releases/2026/01/260112211455.htm Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at the University of Basel created a new test that tracks individual bacteria to see which drugs truly eliminate them. When tested on tuberculosis and other serious lung infections, the method revealed big differences in how bacteria tolerate treatment. The findings could lead to more precise therapies and better predictions of treatment success. Mon, 12 Jan 2026 21:33:16 EST https://www.sciencedaily.com/releases/2026/01/260112211455.htm https://www.sciencedaily.com/releases/2026/01/260110211204.htm In a striking real-world experiment, flu patients spent days indoors with healthy volunteers, but the virus never spread. Researchers found that limited coughing and well-mixed indoor air kept virus levels low, even with close contact. Age may have helped too, since middle-aged adults are less likely to catch the flu than younger people. The results highlight ventilation, air movement, and masks as key defenses against infection. Sun, 11 Jan 2026 02:45:57 EST https://www.sciencedaily.com/releases/2026/01/260110211204.htm https://www.sciencedaily.com/releases/2026/01/260107225532.htm Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabolism. While structured rehab and pacing can improve quality of life, a growing list of experimental treatments—from antivirals and metformin to microbiome therapies and biologics—shows early promise. Clear answers, however, are still limited by small studies and the lack of large, definitive trials. Thu, 08 Jan 2026 19:57:41 EST https://www.sciencedaily.com/releases/2026/01/260107225532.htm https://www.sciencedaily.com/releases/2026/01/260105165820.htm Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead of spreading one virus at a time, infected cells bundle viral material into large structures called Migrions and pass them directly to new cells. This collective delivery jump-starts viral replication and boosts disease severity. The finding reveals a migration-based route of viral spread that defies classic models of infection. Mon, 05 Jan 2026 21:34:44 EST https://www.sciencedaily.com/releases/2026/01/260105165820.htm https://www.sciencedaily.com/releases/2026/01/260105165818.htm A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the antiviral medication, was linked to serious neuropsychiatric events like seizures and hallucinations. Even more striking, kids treated with Tamiflu had about half the risk of these events compared to untreated children with the flu. The results suggest the drug may be protective rather than harmful. Mon, 05 Jan 2026 20:48:09 EST https://www.sciencedaily.com/releases/2026/01/260105165818.htm https://www.sciencedaily.com/releases/2025/12/251227082716.htm Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury. Sat, 27 Dec 2025 10:52:27 EST https://www.sciencedaily.com/releases/2025/12/251227082716.htm https://www.sciencedaily.com/releases/2025/12/251215084218.htm Scientists are uncovering a surprising way to influence bacteria—not by killing them, but by changing how they communicate. Researchers studying oral bacteria found that disrupting chemical signals used in bacterial “conversations” can shift dental plaque toward healthier, less harmful communities. The discovery could open the door to new treatments that prevent disease by maintaining a balanced microbiome rather than wiping bacteria out entirely. Tue, 16 Dec 2025 08:09:37 EST https://www.sciencedaily.com/releases/2025/12/251215084218.htm https://www.sciencedaily.com/releases/2025/12/251214100911.htm Scientists are uncovering a new possibility behind long COVID’s stubborn symptoms: hidden infections that awaken or emerge alongside SARS-CoV-2. Evidence is mounting that viruses like Epstein-Barr and even latent tuberculosis may flare up when COVID disrupts the immune system, creating lingering fatigue, brain fog, and other debilitating issues. Sun, 14 Dec 2025 22:36:14 EST https://www.sciencedaily.com/releases/2025/12/251214100911.htm https://www.sciencedaily.com/releases/2025/12/251213042244.htm Researchers discovered that children who went back to school during COVID experienced far fewer mental health diagnoses than those who stayed remote. Anxiety, depression, and ADHD all declined as in-person learning resumed. Healthcare spending tied to these conditions also dropped. Girls showed the largest improvements, highlighting the importance of school-based structure and support. Sat, 13 Dec 2025 08:28:15 EST https://www.sciencedaily.com/releases/2025/12/251213042244.htm https://www.sciencedaily.com/releases/2025/12/251212204834.htm Researchers used AI to pinpoint a little-known monkeypox protein that provokes strong protective antibodies. When the team tested this protein as a vaccine ingredient in mice, it produced a potent immune response. The discovery could lead to simpler, more effective mpox vaccines and therapies. It may also help guide future efforts against smallpox. Fri, 12 Dec 2025 21:09:27 EST https://www.sciencedaily.com/releases/2025/12/251212204834.htm https://www.sciencedaily.com/releases/2025/12/251211100629.htm Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals. Thu, 11 Dec 2025 22:42:25 EST https://www.sciencedaily.com/releases/2025/12/251211100629.htm https://www.sciencedaily.com/releases/2025/12/251210092015.htm Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, but adapted for whole blood samples. Independent testing showed 100% agreement with existing commercial platforms. Its speed could transform how quickly patients begin treatment. Thu, 11 Dec 2025 02:36:56 EST https://www.sciencedaily.com/releases/2025/12/251210092015.htm https://www.sciencedaily.com/releases/2025/12/251208014623.htm A newly analyzed set of climate data points to a major volcanic eruption that may have played a key role in the Black Death’s arrival. Cooling and crop failures across Europe pushed Italian states to bring in grain from the Black Sea. Those shipments may have carried plague-infected fleas. The study ties together tree rings, ice cores, and historical writings to reframe how the pandemic began. Mon, 08 Dec 2025 03:29:31 EST https://www.sciencedaily.com/releases/2025/12/251208014623.htm https://www.sciencedaily.com/releases/2025/12/251207031338.htm Garlic extract is emerging as a surprisingly powerful contender to chlorhexidine, the long-standing “gold standard” in antimicrobial mouthwashes. A systematic review of clinical studies shows that higher-concentration garlic mouthwash can rival chlorhexidine in killing bacteria—sometimes outperforming it—while offering a more natural alternative. Mon, 08 Dec 2025 01:16:29 EST https://www.sciencedaily.com/releases/2025/12/251207031338.htm https://www.sciencedaily.com/releases/2025/12/251204024226.htm Scientists have captured a never-before-seen, high-resolution look at influenza’s stealthy invasion of human cells, revealing that the cells aren’t just helpless victims. Using a groundbreaking imaging technique, researchers discovered that our cells actually reach out and “grab” the virus as it searches for the perfect entry point, surfing along the membrane. Thu, 04 Dec 2025 03:46:07 EST https://www.sciencedaily.com/releases/2025/12/251204024226.htm https://www.sciencedaily.com/releases/2025/12/251203004721.htm A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect. Wed, 03 Dec 2025 10:22:27 EST https://www.sciencedaily.com/releases/2025/12/251203004721.htm https://www.sciencedaily.com/releases/2025/11/251128050503.htm Researchers discovered why bird flu can survive temperatures that stop human flu in its tracks. A key gene, PB1, gives avian viruses the ability to replicate even at fever-level heat. Mice experiments confirmed that fever cripples human-origin flu but not avian strains, especially those with avian-like PB1. These findings highlight how gene swapping could fuel future pandemics. Fri, 28 Nov 2025 07:37:38 EST https://www.sciencedaily.com/releases/2025/11/251128050503.htm https://www.sciencedaily.com/releases/2025/11/251124094334.htm University of Queensland researchers visualized yellow fever virus particles at near-atomic detail, uncovering major structural differences between vaccine and virulent strains. The insights could lead to better vaccines and treatments for yellow fever and related mosquito-borne viruses. Thu, 27 Nov 2025 09:30:23 EST https://www.sciencedaily.com/releases/2025/11/251124094334.htm